PDL BioPharma to Present at the Oppenheimer 27th Annual Healthcare Conference

INCLINE VILLAGE, Nev., March 14, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's president and chief executive officer, will present at the Oppenheimer 27^th Annual Healthcare Conference next week in New York. The session will be webcast live and will occur on Tuesday, March 21, 2017 at 8:35 a.m. EDT.

To access the live and subsequently archived webcast of the presentation, go to the company's website at http://www.pdl.com and go to "Presentations and Events." Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary. The archived webcast will be available for at least seven days following the presentation.

About PDL BioPharma
PDL seeks to provide a significant return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries.  In late 2012, PDL began providing alternative sources of capital through royalty monetizations and debt facilities and in 2016, began making equity investments in commercial stage companies, the first being Noden Pharma DAC.  PDL has committed over $1.4 billion and funded approximately $1.1 billion in these investments to date.  PDL is headquartered in Incline Village, Nevada. 

NOTE:  PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Logo - http://photos.prnewswire.com/prnh/20110822/SF55808LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pdl-biopharma-to-present-at-the-oppenheimer-27th-annual-healthcare-conference-300422096.html

SOURCE PDL BioPharma, Inc.